Larson Financial Group »

Outlook Therapeutics shares owned by Larson Financial Group

Quarter-by-quarter ownership of Outlook Therapeutics shares owned by Larson Financial Group from 13F filings

Historical chart of Larson Financial Group investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by Larson Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by Larson Financial Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $788 2.0k 0.39
2023-09-30 $442 2.0k 0.22
2023-06-30 $3.5k 2.0k 1.74
2023-03-31 $2.2k 2.0k 1.09
2022-12-31 $2.2k 2.0k 1.08

More positions owned by Larson Financial Group

Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
American Centy Etf Tr Avantis Emgmkt (AVEM)
Dimensional Etf Trust Intl Small Cap E (DFIS)
First Tr Exchng Traded Fd Vi Tcw Unconstrai (UCON)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Vanguard Index Fds Sml Cp Grw Etf (VBK)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Spdr Ser Tr Portfolio Agrgte (SPAB)
Spdr Ser Tr Portfolio S&p500 (SPLG)
First Tr Exchng Traded Fd Vi Tcw Opportunis (FIXD)

View all positions for Larson Financial Group

Top funds holding Outlook Therapeutics

Vanguard Group
Rosalind Advisors
Scotia Capital
Millennium Management
Bank of America Corporation
Barclays
Rhumbline Advisers
UBS Group
Ancora Advisors
Jpmorgan Chase & Co
Alliancebernstein
American International
Captrust Financial Advisors
Virtu Financial
Goldman Sachs Group

View all funds holding Outlook Therapeutics